1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-362
PAR-25-362National Institutes of HealthR01

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Deadline
2026-10-05
32 days left
Award ceiling
$400,000
Awards
—
Posted
2024-12-30

Summary

The purpose of this Notice of Funding Opportunity (NOFO) is to further elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART). […]

The rest of this announcement — free with an account

  • →The full announcement text, not the first two sentences
  • →All 3 review criteria reviewers score this against, extracted from this announcement
  • →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
  • →What similar funded projects received, from 219,000 past awards
Create free accountSign in

No card required. Browsing and your first match are free.

arts-humanitiesimmunologyinfectious-disease

More from National Institutes of Health

See all →
RFA-RM-27-003 • National Institutes of Health

NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)

The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.

3 review criteria on file
amount not statedDue 2026-09-030 days left
PA-27-102 • National Institutes of Health

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-101 • National Institutes of Health

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

S. technology development and commercialization.

7 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-100 • National Institutes of Health

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left

Also in arts-humanities

P26AS00060 • National Park Service

Southwest Border Resource Protection Program

The Southwest Border Resource Protection Program (SWBRPP) provides financial assistance to National Park Service (NPS) units, as well as educational institutions, nonprofit organizations, tribes, and local and state agencies to improve resource stewardship, achieve international cooperation, provide meaningful interpretation and conduct…

$50,000award ceilingDue 2026-09-085 days left
25-543 • U.S. National Science Foundation

Computer and Information Science and Engineering (CISE): Future Computing Research

The NSF CISE Directorate supports research and education projects that develop new knowledge in all aspects of computing, communications, and information science and engineering through the following Future Computing Research (Future CoRe) programs: Algorithmic Foundations (AF) program; Communications and Information Foundations (CIF)…

2 review criteria on file · agency framework
$12,000,000award ceilingDue 2026-09-107 days left
2027FCAH01 • National Endowment for the Arts

NEA Arts and Artifacts International Indemnity Program 1, FY2027 (9/26)

gov for more information.

$100,000award ceilingDue 2026-09-1411 days left

Official announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-362.htmlSource: nih_guide+grants_gov. Always confirm dates with the funder.